121 related articles for article (PubMed ID: 16113802)
1. Pharmacological properties of YM-254890, a specific G(alpha)q/11 inhibitor, on thrombosis and neointima formation in mice.
Kawasaki T; Taniguchi M; Moritani Y; Uemura T; Shigenaga T; Takamatsu H; Hayashi K; Takasaki J; Saito T; Nagai K
Thromb Haemost; 2005 Jul; 94(1):184-92. PubMed ID: 16113802
[TBL] [Abstract][Full Text] [Related]
2. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic and thrombolytic efficacy of YM-254890, a G q/11 inhibitor, in a rat model of arterial thrombosis.
Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Nagai K; Inagaki O; Shikama H
Thromb Haemost; 2003 Sep; 90(3):406-13. PubMed ID: 12958608
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice.
Iwatsuki Y; Kawasaki T; Hayashi K; Moritani Y; Nii T; Miyata K
Thromb Haemost; 2004 Dec; 92(6):1221-8. PubMed ID: 15583727
[TBL] [Abstract][Full Text] [Related]
5. Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats.
Uemura T; Takamatsu H; Kawasaki T; Taniguchi M; Yamamoto E; Tomura Y; Uchida W; Miyata K
Eur J Pharmacol; 2006 Apr; 536(1-2):154-61. PubMed ID: 16566917
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery.
Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T
Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011
[TBL] [Abstract][Full Text] [Related]
7. Neointima formation in injured hamster carotid artery is effectively prevented by the combination G4120 and quinapril.
Matsuno H; Stassen JM; Moons L; Vermylen J; Hoylaerts MF
Thromb Haemost; 1996 Aug; 76(2):263-9. PubMed ID: 8865543
[TBL] [Abstract][Full Text] [Related]
8. Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
Ohno K; Tomizawa A; Jakubowski JA; Mizuno M; Sugidachi A
Thromb Res; 2015 Dec; 136(6):1245-51. PubMed ID: 26489728
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.
Collen D; Lu HR; Stassen JM; Vreys I; Yasuda T; Bunting S; Gold HK
Thromb Haemost; 1994 Jan; 71(1):95-102. PubMed ID: 8165652
[TBL] [Abstract][Full Text] [Related]
10. Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for G
Meleka MM; Edwards AJ; Xia J; Dahlen SA; Mohanty I; Medcalf M; Aggarwal S; Moeller KD; Mortensen OV; Osei-Owusu P
Pharmacol Res; 2019 Mar; 141():264-275. PubMed ID: 30634050
[TBL] [Abstract][Full Text] [Related]
11. Vascular wound healing and neointima formation induced by perivascular electric injury in mice.
Carmeliet P; Moons L; Stassen JM; De Mol M; Bouché A; van den Oord JJ; Kockx M; Collen D
Am J Pathol; 1997 Feb; 150(2):761-76. PubMed ID: 9033288
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
[TBL] [Abstract][Full Text] [Related]
13. Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis.
Evans DJ; Jackman LE; Chamberlain J; Crosdale DJ; Judge HM; Jetha K; Norman KE; Francis SE; Storey RF
Circulation; 2009 Jan; 119(1):116-22. PubMed ID: 19103996
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-induced osteopontin expression in vascular smooth muscle cells involves Gq/11, Ras, ERK, Src and Ets-1.
Abe K; Nakashima H; Ishida M; Miho N; Sawano M; Soe NN; Kurabayashi M; Chayama K; Yoshizumi M; Ishida T
Hypertens Res; 2008 May; 31(5):987-98. PubMed ID: 18712054
[TBL] [Abstract][Full Text] [Related]
15. YM-254890 analogues, novel cyclic depsipeptides with Galpha(q/11) inhibitory activity from Chromobacterium sp. QS3666.
Taniguchi M; Suzumura K; Nagai K; Kawasaki T; Takasaki J; Sekiguchi M; Moritani Y; Saito T; Hayashi K; Fujita S; Tsukamoto S; Suzuki K
Bioorg Med Chem; 2004 Jun; 12(12):3125-33. PubMed ID: 15158780
[TBL] [Abstract][Full Text] [Related]
16. Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice.
Momi S; Pitchford SC; Alberti PF; Minuz P; Del Soldato P; Gresele P
Thromb Haemost; 2005 Mar; 93(3):535-43. PubMed ID: 15735806
[TBL] [Abstract][Full Text] [Related]
17. Functional evidence for biased inhibition of G protein signaling by YM-254890 in human coronary artery endothelial cells.
Peng Q; Alqahtani S; Nasrullah MZA; Shen J
Eur J Pharmacol; 2021 Jan; 891():173706. PubMed ID: 33152337
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies of an orally-active factor Xa inhibitor, YM-60828, with other antithrombotic agents in a rat model of arterial thrombosis.
Kawasaki T; Sato K; Sakai Y; Hirayama F; Koshio H; Taniuchi Y; Matsumoto Y
Thromb Haemost; 1998 Feb; 79(2):410-6. PubMed ID: 9493600
[TBL] [Abstract][Full Text] [Related]
19. Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development.
Kawasaki T; Dewerchin M; Lijnen HR; Vreys I; Vermylen J; Hoylaerts MF
Circ Res; 2001 Feb; 88(2):159-66. PubMed ID: 11157667
[TBL] [Abstract][Full Text] [Related]
20. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
Holy EW; Jakob P; Eickner T; Camici GG; Beer JH; Akhmedov A; Sternberg K; Schmitz KP; Lüscher TF; Tanner FC
Eur Heart J; 2014 Mar; 35(12):808-20. PubMed ID: 24334406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
